The Library
Browse by Warwick Author
Up a level |
Jump to: Academy of Medical Sciences (Great Britain) | Addenbrooke's NHS Trust (Cambridge, England) | Association for International Cancer Research (AICR) | Associazione italiana per la ricerca sul cancro (AIRC) | Breakthrough Breast Cancer | Bristol-Myers Squibb Company | Cambridge Biomedical Research Centre (BMRC) | Cambridge Experimental Cancer Medicine Centre | Cancer Research Campaign (Great Britain) (CRC) | Cancer Research UK (CRUK) | Eli Lilly and Company | European Union (EU) | GlaxoSmithKline | Institute of Cancer Research: Royal Cancer Hospital | Leukaemia Research Appeal for Wales | Leukaemia Research UK (LRUK) | Medical Research Council (Great Britain) (MRC) | NHS Health Scotland | NIHR Cambridge Biomedical Research Centre | National Institute for Health Research (Great Britain) (NIHR) | National Institute for Health Research Health Technology Assessment (Great Britain) (NIHR HTA) | Pathological society of Great Britain and Ireland | Pfizer Inc. | Pharmacia Corp. | Roche | Sanofi Aventis (Firm) | Scottish Breast Cancer Clinical Trials Group | Scottish Cancer Therapy Network (SCTN) | Seventh Framework Programme (European Commission) (FP7) | United States. Public Health Service (PHS) | Welsh Bone Marrow Transplant Research Fund
Number of items: 48.
Academy of Medical Sciences (Great Britain)
Ali, H. Raza, Dariush, Aliakbar, Provenzano, Elena, Bardwell, Helen, Abraham, Jean E., Iddawela, Mahesh, Vallier, Anne-Laure, Hiller, Louise, Dunn, Janet A., Bowden, Sarah J., Hickish, Tamas, McAdam, Karen, Houston, Stephen, Irwin, Mike J., Pharoah, Paul D. P., Brenton, James D., Walton, Nicholas A., Earl, Helena M. and Caldas, Carlos (2016) Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Research, 18 (1). 21. doi:10.1186/s13058-016-0682-8 ISSN 1465-542X.
Addenbrooke's NHS Trust (Cambridge, England)
Abraham, Jean E., Hiller, Louise, Dorling, Leila, Vallier, Anne-Laure, Dunn, Janet A., Bowden, Sarah, Ingle, Susan, Jones, Linda, Hardy, Richard, Twelves, Christopher, Poole, Christopher J., Pharoah, Paul D. P., Caldas, Carlos and Earl, Helena M. (2015) A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine, 13 (1). 306. doi:10.1186/s12916-015-0547-5 ISSN 1741-7015.
Association for International Cancer Research (AICR)
Hannigan, Adèle, Smith, Paul J., Kalna, Gabriela, Lo Nigro, Cristiana, Orange, Clare, O'Brien, Darren I., Shah, Reshma, Syed, Nelofer, Spender, Lindsay C., Herrera, Blanca et al.
(2010)
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.
Journal of Clinical Investigation, Vol.120
(No.8).
pp. 2842-2857.
doi:10.1172/JCI36125
ISSN 0021-9738.
Associazione italiana per la ricerca sul cancro (AIRC)
Hannigan, Adèle, Smith, Paul J., Kalna, Gabriela, Lo Nigro, Cristiana, Orange, Clare, O'Brien, Darren I., Shah, Reshma, Syed, Nelofer, Spender, Lindsay C., Herrera, Blanca et al.
(2010)
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.
Journal of Clinical Investigation, Vol.120
(No.8).
pp. 2842-2857.
doi:10.1172/JCI36125
ISSN 0021-9738.
Breakthrough Breast Cancer
Hannigan, Adèle, Smith, Paul J., Kalna, Gabriela, Lo Nigro, Cristiana, Orange, Clare, O'Brien, Darren I., Shah, Reshma, Syed, Nelofer, Spender, Lindsay C., Herrera, Blanca et al.
(2010)
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.
Journal of Clinical Investigation, Vol.120
(No.8).
pp. 2842-2857.
doi:10.1172/JCI36125
ISSN 0021-9738.
Bristol-Myers Squibb Company
Abraham, Jean E., Hiller, Louise, Dorling, Leila, Vallier, Anne-Laure, Dunn, Janet A., Bowden, Sarah, Ingle, Susan, Jones, Linda, Hardy, Richard, Twelves, Christopher, Poole, Christopher J., Pharoah, Paul D. P., Caldas, Carlos and Earl, Helena M. (2015) A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine, 13 (1). 306. doi:10.1186/s12916-015-0547-5 ISSN 1741-7015.
Cambridge Biomedical Research Centre (BMRC)
Gounaris, I., Provenzano, E., Vallier, A. L., Hiller, Louise, Iddawela, M., Hilborne, S., Taylor, K. (Kathryn), Britton, Peter, Earl, Helena M. and Sinnatamby, R. (2011) Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Research and Treatment, Volume 127 (Number 2). pp. 459-469. doi:10.1007/s10549-011-1454-x ISSN 0167-6806.
Cambridge Experimental Cancer Medicine Centre
Provenzano, E., Vallier, A. -L., Champ, R., Walland, K., Bowden, S. (Sarah), Grier, Anna, Fenwick, Nicola, Abraham, J. (Janet), Iddawela, M., Caldas, C., Hiller, Louise, Dunn, Janet A. and Earl, Helena M. (2013) A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial. British Journal of Cancer, Volume 108 (Number 4). pp. 866-872. doi:10.1038/bjc.2012.547 ISSN 0007-0920.
Cancer Research Campaign (Great Britain) (CRC)
Behalf NEAT Investigators (Including: Earl, Helena M., Hiller, Louise, Dunn, Janet A., Bathers, S., Harvey, P., Stanley, A., Grieve, R. J., Agrawal, R. K., Fernando, I. N., Brunt, A. M., McAdam, K., O'Reilly, S., Rea, D. W., Spooner, David A. and Poole, Christopher). (2008) NEAT : national epirubicin adjuvant trial - toxicity, delivered dose intensity and quality of life. British Journal of Cancer, Vol.99 (No.8). pp. 1226-1231. doi:10.1038/sj.bjc.6604674 ISSN 0007-0920.
Cancer Research UK (CRUK)
Ali, H. Raza, Dariush, Aliakbar, Provenzano, Elena, Bardwell, Helen, Abraham, Jean E., Iddawela, Mahesh, Vallier, Anne-Laure, Hiller, Louise, Dunn, Janet A., Bowden, Sarah J., Hickish, Tamas, McAdam, Karen, Houston, Stephen, Irwin, Mike J., Pharoah, Paul D. P., Brenton, James D., Walton, Nicholas A., Earl, Helena M. and Caldas, Carlos (2016) Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Research, 18 (1). 21. doi:10.1186/s13058-016-0682-8 ISSN 1465-542X.
Dorling, L, Kar, Siddhartha, Michailidou, Kyriaki, Hiller, Louise, Vallier, Anne-Laure, Ingle, Susan, Hardy, Richard, Bowden, Sarah J., Dunn, Janet A., Twelves, Chris, Poole, Christopher J., Caldas, Carlos, Earl, Helena M., Pharoah, Paul D. P. and Abraham, Jean E. (2016) The relationship between common genetic markers of breast cancer risk and chemotherapy-induced toxicity : a case-control study. PLoS One, 11 (7). e0158984. doi:10.1371/journal.pone.0158984 ISSN 1932-6203.
Abraham, Jean E., Hiller, Louise, Dorling, Leila, Vallier, Anne-Laure, Dunn, Janet A., Bowden, Sarah, Ingle, Susan, Jones, Linda, Hardy, Richard, Twelves, Christopher, Poole, Christopher J., Pharoah, Paul D. P., Caldas, Carlos and Earl, Helena M. (2015) A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine, 13 (1). 306. doi:10.1186/s12916-015-0547-5 ISSN 1741-7015.
Earl, Helena M., Hiller, Louise, Dunn, Janet A., Blenkinsop, Clare, Grybowicz, Louise, Vallier, Anne-Laure, Abraham, Jean, Thomas, Jeremy, Provenzano, Elena, Hughes-Davies, Luke et al.
(2015)
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis) : an open-label, randomised, phase 3 trial.
The Lancet Oncology, 16
(6).
pp. 656-666.
doi:10.1016/S1470-2045(15)70137-3
ISSN 1470-2045.
Pirie, Ailith, Guo, Qi, Kraft, Peter, Canisius, Sander, Eccles, Diana M, Rahman, Nazneen, Nevanlinna, Heli, Chen, Constance, Khan, Sofia, Tyrer, Jonathan et al.
(2015)
Common germline polymorphisms associated with breast cancer-specific survival.
Breast Cancer Research, 17
(1).
58.
doi:10.1186/s13058-015-0570-7
ISSN 1465-542X.
Provenzano, E., Vallier, A. -L., Champ, R., Walland, K., Bowden, S. (Sarah), Grier, Anna, Fenwick, Nicola, Abraham, J. (Janet), Iddawela, M., Caldas, C., Hiller, Louise, Dunn, Janet A. and Earl, Helena M. (2013) A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial. British Journal of Cancer, Volume 108 (Number 4). pp. 866-872. doi:10.1038/bjc.2012.547 ISSN 0007-0920.
Hannigan, Adèle, Smith, Paul J., Kalna, Gabriela, Lo Nigro, Cristiana, Orange, Clare, O'Brien, Darren I., Shah, Reshma, Syed, Nelofer, Spender, Lindsay C., Herrera, Blanca et al.
(2010)
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.
Journal of Clinical Investigation, Vol.120
(No.8).
pp. 2842-2857.
doi:10.1172/JCI36125
ISSN 0021-9738.
Bartlett, John M. S., Munro, Alison F., Dunn, Janet A., McConkey, Christopher C., Jordan, S., Twelves, Chris, Cameron, D., Thomas, Jeremy St. J., Campbell, Fiona M., Rea, Daniel W., Provenzano, Elena, Caldas, Carlos, Pharaoh, Paul, Hiller, Louise, Earl, Helena M. and Poole, Christopher (2010) Predictive markers of anthracycline benefit : a prospectively planned analysis of the UK national epirubicin adjuvant trial (NEAT/BR9601). Lancet Oncology, Vol.11 (No.3). pp. 266-274. doi:10.1016/S1470-2045(10)70006-1 ISSN 1470-2045.
Poole, Christopher J., Earl, Helena M., Hiller, Louise, Dunn, Janet A., Bathers, Sarah, Grieve, Robert J., Spooner, David A., Agrawal, Rajiv K., Brunt, A. Murray, OβReilly, Susan M. et al.
(2006)
Epirubicin and cyclophosphamide, methotrexate,
and fluorouracil as adjuvant therapy for early breast cancer.
New England Journal of Medicine, Vol.355
(No.18).
pp. 1851-1862.
doi:10.1056/NEJMoa052084
ISSN 0028-4793.
Eli Lilly and Company
Abraham, Jean E., Hiller, Louise, Dorling, Leila, Vallier, Anne-Laure, Dunn, Janet A., Bowden, Sarah, Ingle, Susan, Jones, Linda, Hardy, Richard, Twelves, Christopher, Poole, Christopher J., Pharoah, Paul D. P., Caldas, Carlos and Earl, Helena M. (2015) A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine, 13 (1). 306. doi:10.1186/s12916-015-0547-5 ISSN 1741-7015.
Provenzano, E., Vallier, A. -L., Champ, R., Walland, K., Bowden, S. (Sarah), Grier, Anna, Fenwick, Nicola, Abraham, J. (Janet), Iddawela, M., Caldas, C., Hiller, Louise, Dunn, Janet A. and Earl, Helena M. (2013) A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial. British Journal of Cancer, Volume 108 (Number 4). pp. 866-872. doi:10.1038/bjc.2012.547 ISSN 0007-0920.
European Union (EU)
Pirie, Ailith, Guo, Qi, Kraft, Peter, Canisius, Sander, Eccles, Diana M, Rahman, Nazneen, Nevanlinna, Heli, Chen, Constance, Khan, Sofia, Tyrer, Jonathan et al.
(2015)
Common germline polymorphisms associated with breast cancer-specific survival.
Breast Cancer Research, 17
(1).
58.
doi:10.1186/s13058-015-0570-7
ISSN 1465-542X.
GlaxoSmithKline
Scott, R. A., Freitag, D. F., Li, L., Chu, A. Y., Surendran, P., Young, R., Grarup, N., Stancakova, A., Chen, Y., Varga, T. V. et al.
(2016)
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.
Science Translational Medicine, 8
(341).
341ra76.
doi:10.1126/scitranslmed.aad3744
ISSN 1946-6234.
Institute of Cancer Research: Royal Cancer Hospital
Hannigan, Adèle, Smith, Paul J., Kalna, Gabriela, Lo Nigro, Cristiana, Orange, Clare, O'Brien, Darren I., Shah, Reshma, Syed, Nelofer, Spender, Lindsay C., Herrera, Blanca et al.
(2010)
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.
Journal of Clinical Investigation, Vol.120
(No.8).
pp. 2842-2857.
doi:10.1172/JCI36125
ISSN 0021-9738.
Leukaemia Research Appeal for Wales
Pepper, Chris, Lin, Thet Thet, Pratt, Guy, Hewamana, Saman, Brennan, Paul , Hiller, Louise, Hills, R., Ward, Rachel, Starczynski, Jane, Austen, Belinda, Hooper, Laura, Stankovic, Tatjana and Fegan, Chris (2008) Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood, Vol.112 (No.9). pp. 3807-3817. doi:10.1182/blood-2008-05-157131 ISSN 0006-4971.
Leukaemia Research UK (LRUK)
Pepper, Chris, Lin, Thet Thet, Pratt, Guy, Hewamana, Saman, Brennan, Paul , Hiller, Louise, Hills, R., Ward, Rachel, Starczynski, Jane, Austen, Belinda, Hooper, Laura, Stankovic, Tatjana and Fegan, Chris (2008) Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood, Vol.112 (No.9). pp. 3807-3817. doi:10.1182/blood-2008-05-157131 ISSN 0006-4971.
Medical Research Council (Great Britain) (MRC)
Scott, R. A., Freitag, D. F., Li, L., Chu, A. Y., Surendran, P., Young, R., Grarup, N., Stancakova, A., Chen, Y., Varga, T. V. et al.
(2016)
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.
Science Translational Medicine, 8
(341).
341ra76.
doi:10.1126/scitranslmed.aad3744
ISSN 1946-6234.
Abraham, Jean E., Hiller, Louise, Dorling, Leila, Vallier, Anne-Laure, Dunn, Janet A., Bowden, Sarah, Ingle, Susan, Jones, Linda, Hardy, Richard, Twelves, Christopher, Poole, Christopher J., Pharoah, Paul D. P., Caldas, Carlos and Earl, Helena M. (2015) A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine, 13 (1). 306. doi:10.1186/s12916-015-0547-5 ISSN 1741-7015.
NHS Health Scotland
Tennant, Ruth, Hiller, Louise, Fishwick, Ruth, Platt, Stephen, Joseph, Stephen, Weich, Scott, Parkinson, Jane, Secker, Jenny and Stewart-Brown, Sarah L. (2007) The Warwick-Edinburgh Mental Well-being Scale (WEMWBS) : development and UK validation. Health and Quality of Life Outcomes, Vol.5 (No.63). doi:10.1186/1477-7525-5-63 ISSN 1477-7525.
NIHR Cambridge Biomedical Research Centre
Ali, H. Raza, Dariush, Aliakbar, Provenzano, Elena, Bardwell, Helen, Abraham, Jean E., Iddawela, Mahesh, Vallier, Anne-Laure, Hiller, Louise, Dunn, Janet A., Bowden, Sarah J., Hickish, Tamas, McAdam, Karen, Houston, Stephen, Irwin, Mike J., Pharoah, Paul D. P., Brenton, James D., Walton, Nicholas A., Earl, Helena M. and Caldas, Carlos (2016) Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Research, 18 (1). 21. doi:10.1186/s13058-016-0682-8 ISSN 1465-542X.
Abraham, Jean E., Hiller, Louise, Dorling, Leila, Vallier, Anne-Laure, Dunn, Janet A., Bowden, Sarah, Ingle, Susan, Jones, Linda, Hardy, Richard, Twelves, Christopher, Poole, Christopher J., Pharoah, Paul D. P., Caldas, Carlos and Earl, Helena M. (2015) A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine, 13 (1). 306. doi:10.1186/s12916-015-0547-5 ISSN 1741-7015.
National Institute for Health Research (Great Britain) (NIHR)
Ali, H. Raza, Dariush, Aliakbar, Provenzano, Elena, Bardwell, Helen, Abraham, Jean E., Iddawela, Mahesh, Vallier, Anne-Laure, Hiller, Louise, Dunn, Janet A., Bowden, Sarah J., Hickish, Tamas, McAdam, Karen, Houston, Stephen, Irwin, Mike J., Pharoah, Paul D. P., Brenton, James D., Walton, Nicholas A., Earl, Helena M. and Caldas, Carlos (2016) Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Research, 18 (1). 21. doi:10.1186/s13058-016-0682-8 ISSN 1465-542X.
Dorling, L, Kar, Siddhartha, Michailidou, Kyriaki, Hiller, Louise, Vallier, Anne-Laure, Ingle, Susan, Hardy, Richard, Bowden, Sarah J., Dunn, Janet A., Twelves, Chris, Poole, Christopher J., Caldas, Carlos, Earl, Helena M., Pharoah, Paul D. P. and Abraham, Jean E. (2016) The relationship between common genetic markers of breast cancer risk and chemotherapy-induced toxicity : a case-control study. PLoS One, 11 (7). e0158984. doi:10.1371/journal.pone.0158984 ISSN 1932-6203.
Provenzano, E., Vallier, A. -L., Champ, R., Walland, K., Bowden, S. (Sarah), Grier, Anna, Fenwick, Nicola, Abraham, J. (Janet), Iddawela, M., Caldas, C., Hiller, Louise, Dunn, Janet A. and Earl, Helena M. (2013) A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial. British Journal of Cancer, Volume 108 (Number 4). pp. 866-872. doi:10.1038/bjc.2012.547 ISSN 0007-0920.
Gounaris, I., Provenzano, E., Vallier, A. L., Hiller, Louise, Iddawela, M., Hilborne, S., Taylor, K. (Kathryn), Britton, Peter, Earl, Helena M. and Sinnatamby, R. (2011) Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Research and Treatment, Volume 127 (Number 2). pp. 459-469. doi:10.1007/s10549-011-1454-x ISSN 0167-6806.
National Institute for Health Research Health Technology Assessment (Great Britain) (NIHR HTA)
Earl, Helena M, Vallier, Anne-Laure, Dunn, Janet A., Loi, Shrushma, Ogburn, Emma, McAdam, Karen, Hughes-Davies, Luke, Harnett, Adrian, Abraham, Jean, Wardley, Andrew, Cameron, David A, Miles, David, Gounaris, Ioannis, Plummer, Chris and Hiller, Louise (2016) Trastuzumab-associated cardiac events in the Persephone trial. British Journal of Cancer, 115 (12). pp. 1462-1470. doi:10.1038/bjc.2016.357 ISSN 0007-0920.
Pathological society of Great Britain and Ireland
Ali, H. Raza, Dariush, Aliakbar, Provenzano, Elena, Bardwell, Helen, Abraham, Jean E., Iddawela, Mahesh, Vallier, Anne-Laure, Hiller, Louise, Dunn, Janet A., Bowden, Sarah J., Hickish, Tamas, McAdam, Karen, Houston, Stephen, Irwin, Mike J., Pharoah, Paul D. P., Brenton, James D., Walton, Nicholas A., Earl, Helena M. and Caldas, Carlos (2016) Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Research, 18 (1). 21. doi:10.1186/s13058-016-0682-8 ISSN 1465-542X.
Pfizer Inc.
Abraham, Jean E., Hiller, Louise, Dorling, Leila, Vallier, Anne-Laure, Dunn, Janet A., Bowden, Sarah, Ingle, Susan, Jones, Linda, Hardy, Richard, Twelves, Christopher, Poole, Christopher J., Pharoah, Paul D. P., Caldas, Carlos and Earl, Helena M. (2015) A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine, 13 (1). 306. doi:10.1186/s12916-015-0547-5 ISSN 1741-7015.
Poole, Christopher J., Earl, Helena M., Hiller, Louise, Dunn, Janet A., Bathers, Sarah, Grieve, Robert J., Spooner, David A., Agrawal, Rajiv K., Brunt, A. Murray, OβReilly, Susan M. et al.
(2006)
Epirubicin and cyclophosphamide, methotrexate,
and fluorouracil as adjuvant therapy for early breast cancer.
New England Journal of Medicine, Vol.355
(No.18).
pp. 1851-1862.
doi:10.1056/NEJMoa052084
ISSN 0028-4793.
Pharmacia Corp.
Bartlett, John M. S., Munro, Alison F., Dunn, Janet A., McConkey, Christopher C., Jordan, S., Twelves, Chris, Cameron, D., Thomas, Jeremy St. J., Campbell, Fiona M., Rea, Daniel W., Provenzano, Elena, Caldas, Carlos, Pharaoh, Paul, Hiller, Louise, Earl, Helena M. and Poole, Christopher (2010) Predictive markers of anthracycline benefit : a prospectively planned analysis of the UK national epirubicin adjuvant trial (NEAT/BR9601). Lancet Oncology, Vol.11 (No.3). pp. 266-274. doi:10.1016/S1470-2045(10)70006-1 ISSN 1470-2045.
Behalf NEAT Investigators (Including: Earl, Helena M., Hiller, Louise, Dunn, Janet A., Bathers, S., Harvey, P., Stanley, A., Grieve, R. J., Agrawal, R. K., Fernando, I. N., Brunt, A. M., McAdam, K., O'Reilly, S., Rea, D. W., Spooner, David A. and Poole, Christopher). (2008) NEAT : national epirubicin adjuvant trial - toxicity, delivered dose intensity and quality of life. British Journal of Cancer, Vol.99 (No.8). pp. 1226-1231. doi:10.1038/sj.bjc.6604674 ISSN 0007-0920.
Roche
Earl, Helena M, Vallier, Anne-Laure, Dunn, Janet A., Loi, Shrushma, Ogburn, Emma, McAdam, Karen, Hughes-Davies, Luke, Harnett, Adrian, Abraham, Jean, Wardley, Andrew, Cameron, David A, Miles, David, Gounaris, Ioannis, Plummer, Chris and Hiller, Louise (2016) Trastuzumab-associated cardiac events in the Persephone trial. British Journal of Cancer, 115 (12). pp. 1462-1470. doi:10.1038/bjc.2016.357 ISSN 0007-0920.
Earl, Helena M., Hiller, Louise, Dunn, Janet A., Blenkinsop, Clare, Grybowicz, Louise, Vallier, Anne-Laure, Abraham, Jean, Thomas, Jeremy, Provenzano, Elena, Hughes-Davies, Luke et al.
(2015)
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis) : an open-label, randomised, phase 3 trial.
The Lancet Oncology, 16
(6).
pp. 656-666.
doi:10.1016/S1470-2045(15)70137-3
ISSN 1470-2045.
Sanofi Aventis (Firm)
Earl, Helena M., Hiller, Louise, Dunn, Janet A., Blenkinsop, Clare, Grybowicz, Louise, Vallier, Anne-Laure, Abraham, Jean, Thomas, Jeremy, Provenzano, Elena, Hughes-Davies, Luke et al.
(2015)
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis) : an open-label, randomised, phase 3 trial.
The Lancet Oncology, 16
(6).
pp. 656-666.
doi:10.1016/S1470-2045(15)70137-3
ISSN 1470-2045.
Scottish Breast Cancer Clinical Trials Group
Bartlett, John M. S., Munro, Alison F., Dunn, Janet A., McConkey, Christopher C., Jordan, S., Twelves, Chris, Cameron, D., Thomas, Jeremy St. J., Campbell, Fiona M., Rea, Daniel W., Provenzano, Elena, Caldas, Carlos, Pharaoh, Paul, Hiller, Louise, Earl, Helena M. and Poole, Christopher (2010) Predictive markers of anthracycline benefit : a prospectively planned analysis of the UK national epirubicin adjuvant trial (NEAT/BR9601). Lancet Oncology, Vol.11 (No.3). pp. 266-274. doi:10.1016/S1470-2045(10)70006-1 ISSN 1470-2045.
Scottish Cancer Therapy Network (SCTN)
Bartlett, John M. S., Munro, Alison F., Dunn, Janet A., McConkey, Christopher C., Jordan, S., Twelves, Chris, Cameron, D., Thomas, Jeremy St. J., Campbell, Fiona M., Rea, Daniel W., Provenzano, Elena, Caldas, Carlos, Pharaoh, Paul, Hiller, Louise, Earl, Helena M. and Poole, Christopher (2010) Predictive markers of anthracycline benefit : a prospectively planned analysis of the UK national epirubicin adjuvant trial (NEAT/BR9601). Lancet Oncology, Vol.11 (No.3). pp. 266-274. doi:10.1016/S1470-2045(10)70006-1 ISSN 1470-2045.
Seventh Framework Programme (European Commission) (FP7)
Pirie, Ailith, Guo, Qi, Kraft, Peter, Canisius, Sander, Eccles, Diana M, Rahman, Nazneen, Nevanlinna, Heli, Chen, Constance, Khan, Sofia, Tyrer, Jonathan et al.
(2015)
Common germline polymorphisms associated with breast cancer-specific survival.
Breast Cancer Research, 17
(1).
58.
doi:10.1186/s13058-015-0570-7
ISSN 1465-542X.
United States. Public Health Service (PHS)
Hannigan, Adèle, Smith, Paul J., Kalna, Gabriela, Lo Nigro, Cristiana, Orange, Clare, O'Brien, Darren I., Shah, Reshma, Syed, Nelofer, Spender, Lindsay C., Herrera, Blanca et al.
(2010)
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.
Journal of Clinical Investigation, Vol.120
(No.8).
pp. 2842-2857.
doi:10.1172/JCI36125
ISSN 0021-9738.
Welsh Bone Marrow Transplant Research Fund
Pepper, Chris, Lin, Thet Thet, Pratt, Guy, Hewamana, Saman, Brennan, Paul , Hiller, Louise, Hills, R., Ward, Rachel, Starczynski, Jane, Austen, Belinda, Hooper, Laura, Stankovic, Tatjana and Fegan, Chris (2008) Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood, Vol.112 (No.9). pp. 3807-3817. doi:10.1182/blood-2008-05-157131 ISSN 0006-4971.
This list was generated on Thu Apr 25 05:48:35 2024 BST.